Lalitkumar K. Vora
ORCID: 0000-0001-8106-9066Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 10 papers. Top paper: “Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer”.
Susan E. Yost, Yujie Cui, Christopher Ruel, Mireya Murga, Aileen Tang +10 more
Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen +22 more
Ian Bejster, Aaron M. Chadderdon, Cheryl Harteg, Qonita Kurnia Anjani, Akmal Hidayat Bin Sabri +8 more
Farhana Islam, Pallavi Deol, Lubaba A. Zaman, Dina A. Mosselhy, Md Ashaduzzaman +17 more
Rajith K. R. Rajoli, Henry Pertinez, Lalitkumar K. Vora, Fabiana Volpe‐Zanutto, Ryan F. Donnelly +5 more
Sudipta Panja, Ashrafi Sultana, Lubaba A. Zaman, Lalitkumar K. Vora, Brady Sillman +3 more
Sudipta Panja, Ashrafi Sultana, Lubaba A. Zaman, Lalitkumar K. Vora, Brady Sillman +3 more
Sudipta Panja, Ashrafi Sultana, Lubaba A. Zaman, Lalitkumar K. Vora, Brady Sillman +3 more
Yingyu Wang, Chen Chen, Sorena Nadaf, Rebecca Pharaon, Jeremy Fricke +19 more
Arshdeep Sahi, Shikha Aery, Kippeum Lee, Moondeep Chauhan, Yubin Lee +9 more